Literature DB >> 1965327

Opioid and non-opioid central cardiovascular effects of ketamine.

S Seth1, D Mukherjee, A K Choudhary, J N Sinha, S Gurtu.   

Abstract

The cardiovascular responses to ketamine injected intracisternally were examined in chloralose anaesthetized cats. Blood pressure and heart rate were recorded at different time intervals after intracisternal injection of drug or saline vehicle. The low doses of ketamine (0.5 or 1.0 mg) elicited dose dependent increase in blood pressure and heart rate. In contrast the high dose of ketamine (4 mg), produced a fall in blood pressure and heart rate. The cardiovascular response elicited by the low dose was naloxone insensitive and completely blocked by haloperidol, but not by dopamine antagonist pimozide. The vasodepressor and bradycardiac effect of the 4 mg dose was naloxone antagonizable. These data show that excitatory cardiovascular effects of the low dose result from a naloxone resistant site while in high doses an inhibitory effect is elicited by action at naloxone sensitive opiate receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965327     DOI: 10.1007/bf00169042

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

2.  Phencyclidine and sigma opiate receptors in brain: biochemical and autoradiographical differentiation.

Authors:  A L Gundlach; B L Largent; S H Snyder
Journal:  Eur J Pharmacol       Date:  1985-07-31       Impact factor: 4.432

3.  Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats.

Authors:  P Bolme; K Fuxe; L F Agnati; R Bradley; J Smythies
Journal:  Eur J Pharmacol       Date:  1978-04-01       Impact factor: 4.432

4.  The interaction of ketamine with the opiate receptor.

Authors:  D J Smith; G M Pekoe; L L Martin; B Coalgate
Journal:  Life Sci       Date:  1980-03-10       Impact factor: 5.037

5.  (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.

Authors:  S W Tam
Journal:  Eur J Pharmacol       Date:  1985-02-12       Impact factor: 4.432

6.  Circulatory responses to ketamine: dependence on respiratory pattern and background anaesthesia in the rabbit.

Authors:  J C McGrath; J E MacKenzie; R A Millar
Journal:  Br J Anaesth       Date:  1975-11       Impact factor: 9.166

7.  Central cardiovascular effects of narcotic analgesics and enkephalins in rats.

Authors:  M Bellet; J L Elghozi; P Meyer; M G Pernollet; H Schmitt
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Cardiovascular effects of 2-(O-chlorophenyl)-2-methylaminocyclohexanone (CI-581) in rats.

Authors:  P Chang; K E Chan; A Ganendran
Journal:  Br J Anaesth       Date:  1969-05       Impact factor: 9.166

9.  Cardiovascular responses to opioid agonists injected into the nucleus of tractus solitarius of anesthetized cats.

Authors:  A H Hassen; G Z Feuerstein; A I Faden
Journal:  Life Sci       Date:  1982 Nov 15-22       Impact factor: 5.037

10.  Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat.

Authors:  G Feuerstein; A I Faden
Journal:  Life Sci       Date:  1982 Nov 15-22       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.